A. Adam

955 total citations
48 papers, 760 citations indexed

About

A. Adam is a scholar working on Genetics, Immunology and Molecular Biology. According to data from OpenAlex, A. Adam has authored 48 papers receiving a total of 760 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Genetics, 8 papers in Immunology and 7 papers in Molecular Biology. Recurrent topics in A. Adam's work include Coagulation, Bradykinin, Polyphosphates, and Angioedema (34 papers), Mast cells and histamine (6 papers) and Blood Coagulation and Thrombosis Mechanisms (4 papers). A. Adam is often cited by papers focused on Coagulation, Bradykinin, Polyphosphates, and Angioedema (34 papers), Mast cells and histamine (6 papers) and Blood Coagulation and Thrombosis Mechanisms (4 papers). A. Adam collaborates with scholars based in Canada, Belgium and France. A. Adam's co-authors include J. Damas, Nicole Gervais, Philippe Raymond, Adelin Albert, Réjean Couture, M. E. Faymonville, Maurice Lamy, Jean Duchateau, Réginald Nadeau and Jasmin Paulus and has published in prestigious journals such as Journal of Biological Chemistry, Gut and Kidney International.

In The Last Decade

A. Adam

45 papers receiving 736 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Adam Canada 13 390 148 143 138 119 48 760
Antonio Di Gennaro Sweden 13 168 0.4× 81 0.5× 177 1.2× 186 1.3× 28 0.2× 18 679
Gabriele Spohn Germany 14 164 0.4× 99 0.7× 131 0.9× 207 1.5× 29 0.2× 24 813
Naser Mobarra Iran 17 127 0.3× 128 0.9× 41 0.3× 422 3.1× 30 0.3× 45 905
Eva Storm Norway 10 77 0.2× 291 2.0× 65 0.5× 308 2.2× 101 0.8× 12 854
Eric Collard United States 9 129 0.3× 61 0.4× 151 1.1× 121 0.9× 23 0.2× 10 729
Alessandra Consonni Italy 18 60 0.2× 154 1.0× 79 0.6× 248 1.8× 51 0.4× 33 765
Xiao-Li Zheng China 13 170 0.4× 152 1.0× 74 0.5× 155 1.1× 6 0.1× 51 722
Patrícia Dillenburg-Pilla Brazil 9 111 0.3× 24 0.2× 161 1.1× 414 3.0× 47 0.4× 14 851
Pamela Davison United States 13 32 0.1× 52 0.4× 107 0.7× 257 1.9× 57 0.5× 17 745
Günther Konwalinka Austria 13 73 0.2× 63 0.4× 105 0.7× 317 2.3× 11 0.1× 26 669

Countries citing papers authored by A. Adam

Since Specialization
Citations

This map shows the geographic impact of A. Adam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Adam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Adam more than expected).

Fields of papers citing papers by A. Adam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Adam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Adam. The network helps show where A. Adam may publish in the future.

Co-authorship network of co-authors of A. Adam

This figure shows the co-authorship network connecting the top 25 collaborators of A. Adam. A scholar is included among the top collaborators of A. Adam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Adam. A. Adam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Adam, A., et al.. (2024). Determination of the critical aggregation concentration in water of Gum Arabic functionalized with curcumin oxidation products by micro-scale thermophoresis approach. International Journal of Biological Macromolecules. 271(Pt 1). 132510–132510. 4 indexed citations
2.
Désormeaux, Anik, et al.. (2009). Les réactions d’hypersensibilité associées à l’injection intraveineuse d’héparine d’origine chinoise. Annales Pharmaceutiques Françaises. 67(3). 169–172. 1 indexed citations
3.
Moreau, Marie Eve & A. Adam. (2006). Aspect multifactoriel des effets secondaires aigus des inhibiteurs de l′enzyme de conversion de l′angiotensine. Annales Pharmaceutiques Françaises. 64(4). 276–286. 2 indexed citations
4.
Adam, A., et al.. (2001). Bradykinin, an Important Mediator of the Cardiovascular Effects of Metallopeptidase Inhibitors: Experimental and Clinical Evidences. Journal of clinical and basic cardiology. 4(1). 39–46. 7 indexed citations
7.
Adam, A., et al.. (1996). Kinin-Induced Prolongation of Action-Potential Duration in Right Ventricular Muscle from Rat: Involvement of B1 and B2 Receptors. Journal of Cardiovascular Pharmacology. 28(2). 337–343. 7 indexed citations
8.
Ribuot, Christophe, et al.. (1994). Intracoronary infusion of bradykinin: effects on noradrenaline overflow following reperfusion of ischemic myocardium in the anesthetized dog. Fundamental and Clinical Pharmacology. 8(6). 532–538. 9 indexed citations
9.
Chahine, Ramez, A. Adam, N. Yamaguchi, et al.. (1993). Protective effects of bradykinin on the ischaemic heart: implication of the B1 receptor. British Journal of Pharmacology. 108(2). 318–322. 64 indexed citations
10.
Cadena, Raul A. DeLa, et al.. (1992). Role of kallikrein-kinin system in the pathogenesis of bacterial cell wall-induced inflammation and enterocolitis.. PubMed. 105. 229–37. 2 indexed citations
11.
Faymonville, M. E., J. Pincemail, Jean Duchateau, et al.. (1991). Myeloperoxidase and elastase as markers of leukocyte activation during cardiopulmonary bypass in humans. Journal of Thoracic and Cardiovascular Surgery. 102(2). 309–317. 141 indexed citations
12.
Adam, A., Huy Ong, D. Sondag, et al.. (1990). Radioimmunoassay for Albuterol Using a Monoclonal Antibody: Application for Direct Quantification in Horse Urine. Journal of Immunoassay. 11(3). 329–345. 26 indexed citations
13.
Adam, A., J. Damas, & H Kulbertus. (1989). The Kallikrein-Kininogen System in Myocardial Infarction. Advances in experimental medicine and biology. 247A. 369–373. 1 indexed citations
14.
Girolami, Jean‐Pierre, Christiane Pécher, Jean‐Loup Bascands, et al.. (1989). Direct Radioimmunoassay of Active and Inactive Human Glandular Kallikrein: Some Physiological and Pathological Variabilities. Journal of Immunoassay. 10(2-3). 221–236. 3 indexed citations
15.
Damas, J., et al.. (1989). Presence of T‐kininogen and kinins in sponge‐induced exudates in rats. British Journal of Pharmacology. 97(4). 1343–1349. 3 indexed citations
16.
Girolami, Jean‐Pierre, Claudine Orfila, Christiane Pécher, et al.. (1989). Inverse Relationship Between Renal and Urinary Kallikrein During Chromate-Induced Acute Renal Failure in Rat: Urinary Kallikrein Excretion as a Possible Recovery Index. Biological Chemistry Hoppe-Seyler. 370(2). 1305–1314. 8 indexed citations
17.
Damas, J., et al.. (1989). Some Cardiovascular and Hematological Changes Induced in the Rat by Activation of Hageman Factor with Ellagic Acid. Advances in experimental medicine and biology. 247A. 461–465. 3 indexed citations
18.
Damas, J., et al.. (1987). Mechanism of the congestion of lymph nodes induced by ellagic acid in rats. Inflammation Research. 22(3-4). 202–208. 5 indexed citations
19.
Damas, J., et al.. (1987). Studies on the vascular and hematological changes induced by ellagic acid in rats. Inflammation Research. 22(3-4). 270–279. 9 indexed citations
20.
Adam, A.. (1982). [Endogenous mediators in the acute local inflammatory process. Proteins of the acute central phase. Current data and perspectives].. PubMed. 37(24). 852–6. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026